These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29602469)

  • 1. Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers.
    Ponti G; Maccaferri M; Manfredini M; Cotugno M; Pellacani G; Conti A; Micali S; Mandrioli M; Tomasi A
    Med Hypotheses; 2018 May; 114():69. PubMed ID: 29602469
    [No Abstract]   [Full Text] [Related]  

  • 2. Seminal fluid: a useful source of prostate cancer biomarkers?
    Roberts MJ; Richards RS; Gardiner RA; Selth LA
    Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Utility of Biomarkers in Localized Prostate Cancer.
    Leapman MS; Nguyen HG; Cooperberg MR
    Curr Oncol Rep; 2016 May; 18(5):30. PubMed ID: 27023445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of prostate cancer management in the prostate-specific antigen era.
    Sartor O
    Clin Prostate Cancer; 2004 Mar; 2(4):200-1. PubMed ID: 15072599
    [No Abstract]   [Full Text] [Related]  

  • 5. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
    Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
    [No Abstract]   [Full Text] [Related]  

  • 6. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis.
    Ponti G; Maccaferri M; Manfredini M; Micali S; Torricelli F; Milandri R; Del Prete C; Ciarrocchi A; Ruini C; Benassi L; Bettelli S; Kaleci S; Ozben T; Tomasi A
    Clin Chim Acta; 2019 Oct; 497():76-80. PubMed ID: 31301282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
    Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
    Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
    [No Abstract]   [Full Text] [Related]  

  • 8. Reconsidering Prostate Cancer Screening.
    Schmidt C
    J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
    Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
    Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis.
    Siegel C
    J Urol; 2015 Aug; 194(2):395. PubMed ID: 26195367
    [No Abstract]   [Full Text] [Related]  

  • 11. Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.
    Mao C; Ding Y; Xu N
    Mol Cell Biochem; 2022 Jan; 477(1):213-223. PubMed ID: 34655417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate detection possibility.
    Gunby P
    JAMA; 1999 Jun 23-30; 281(24):2274-5. PubMed ID: 10386541
    [No Abstract]   [Full Text] [Related]  

  • 13. Up, up and away with new markers and PSA.
    Bercovich E
    Urol Int; 2000; 65(2):117-9. PubMed ID: 11025435
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Serum proteomic patterns for detection of prostate cancer.
    Diamandis EP
    J Natl Cancer Inst; 2003 Mar; 95(6):489-90; author reply 490-1. PubMed ID: 12644546
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].
    Grond A
    Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population.
    Inoue T; Kinoshita H; Terada N; Kobayashi T; Yamasaki T; Matsui Y; Kamba T; Inui H; Sugi M; Matsuda T; Ogawa O
    Jpn J Clin Oncol; 2015 Aug; 45(8):780-4. PubMed ID: 25981623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for early prostate cancer detection.
    Margreiter M; Stangelberger A; Valimberti E; Herwig R; Djavan B
    Minerva Urol Nefrol; 2008 Mar; 60(1):51-60. PubMed ID: 18427435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for prostate cancer.
    Schiffer E
    World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic specific antigen (PSA).
    Alberti C
    Minerva Urol Nefrol; 1993 Jun; 45(2):83-4. PubMed ID: 7694380
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on the article "Biomarkers for prostate cancer" by Eric Schiffer.
    Marshall S
    World J Urol; 2009 Aug; 27(4):577-8. PubMed ID: 19543735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.